Suda Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
8,648.20
5,624.80
5,785.80
7,197.40
425.90
Cost of Goods Sold (COGS) incl. D&A
8,291.20
7,673.70
7,468.60
7,846.30
1,948.80
Gross Income
357.00
2,048.90
1,682.80
648.90
1,522.90
SG&A Expense
2,294.00
1,718.40
894.10
1,229.60
2,013.30
EBIT
1,999.30
4,080.60
3,002.10
1,941.80
3,536.30
Unusual Expense
-
-
-
-
3,129.90
Non Operating Income/Expense
188.30
97.80
73.20
110.90
62.60
Interest Expense
158.60
156.20
209.60
223.50
177.00
Pretax Income
2,241.20
4,036.20
3,052.60
2,030.30
6,778.10
Income Tax
180.40
657.90
765.80
792.00
745.00
Consolidated Net Income
2,060.90
3,378.30
2,286.80
1,238.30
6,033.10
Net Income
2,060.90
3,367.20
2,286.80
1,238.30
6,033.10
Net Income After Extraordinaries
2,060.90
3,367.20
2,286.80
1,238.30
6,606.90
Net Income Available to Common
2,060.90
3,367.20
2,286.80
1,238.30
6,033.10
EPS (Basic)
0.00
0.00
0.00
0.00
0.00
Basic Shares Outstanding
911,951.60
1,108,065.80
1,243,100.00
1,260,992.60
1,332,720.80
EPS (Diluted)
0.00
0.00
0.00
0.00
0.00
Diluted Shares Outstanding
911,951.60
1,108,065.80
1,243,100.00
1,260,992.60
1,332,720.80
EBITDA
1,932.10
3,899.40
2,879.70
1,817.50
3,378.80
Other Operating Expense
62.30
313.30
425.30
63.30
-
Non-Operating Interest Income
105.00
102.80
85.80
24.00
2.50
Minority Interest Expense
-
11.10
-
-
-

About Suda

View Profile
Address
55 Howe Street
Osborne Park Western Australia (WA) 6017
Australia
Employees -
Website http://www.sudapharma.com
Updated 07/08/2019
Suda Pharmaceuticals Ltd. develops pharmaceuticals and distributes medical devices and consumables. Its activities include pharmaceutical development of drug delivery technology and medical devices and consumables distribution. The company operates through following segment: Suda, Westcoast Surgical and Medical Supplies; and Malaria Research Company.